Shanghai Junshi Biosciences A is a leading biopharmaceutical company based in China. It focuses on the discovery, development, and commercialization of innovative therapies, particularly in oncology and autoimmune diseases, through state-of-the-art research and advanced biotechnology.
Date confirmed from the official Chinese exchange disclosure timetable.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Shanghai Junshi Biosciences A is scheduled to report its next quarterly earnings on 10/30/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Shanghai Junshi Biosciences A last reported quarterly earnings on 8/26/2026 (Q2 2026). Earnings per share (EPS) came in at 0.02 CNY.
Across its last 3 earnings reports, Shanghai Junshi Biosciences A stock moved by ±1.2% on average the following day. The largest reaction was +2.4% on 04/27/2026; 2 of 3 reactions were positive.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Past price reactions are not a reliable indicator of future performance.